Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

This study has been completed.
Information provided by (Responsible Party):
TVAX Biomedical Identifier:
First received: February 3, 2011
Last updated: October 21, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2014
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)